BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 18006467)

  • 1. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
    Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
    Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair.
    Haider HKh; Jiang S; Idris NM; Ashraf M
    Circ Res; 2008 Nov; 103(11):1300-8. PubMed ID: 18948617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats.
    Hou M; Yang KM; Zhang H; Zhu WQ; Duan FJ; Wang H; Song YH; Wei YJ; Hu SS
    Int J Cardiol; 2007 Feb; 115(2):220-8. PubMed ID: 16889848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazoxide preconditioning of endothelial progenitor cells improves their ability to repair the infarcted myocardium.
    Mehmood A; Ali M; Khan SN; Riazuddin S
    Cell Biol Int; 2015 Nov; 39(11):1251-63. PubMed ID: 26032287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells.
    Jiang Q; Song P; Wang E; Li J; Hu S; Zhang H
    J Mol Cell Cardiol; 2013 Mar; 56():1-7. PubMed ID: 23291430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair.
    Shujia J; Haider HK; Idris NM; Lu G; Ashraf M
    Cardiovasc Res; 2008 Feb; 77(3):525-33. PubMed ID: 18032392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model.
    Schuh A; Liehn EA; Sasse A; Hristov M; Sobota R; Kelm M; Merx MW; Weber C
    Basic Res Cardiol; 2008 Jan; 103(1):69-77. PubMed ID: 17999028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
    Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
    Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.
    Li W; Ma N; Ong LL; Nesselmann C; Klopsch C; Ladilov Y; Furlani D; Piechaczek C; Moebius JM; Lützow K; Lendlein A; Stamm C; Li RK; Steinhoff G
    Stem Cells; 2007 Aug; 25(8):2118-27. PubMed ID: 17478584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of SDF-1-CXCR4 axis and an anti-remodelling effectiveness of foetal-liver stem cell transplantation in the infarcted rat heart.
    Czarnowska E; Gajerska-Dzieciatkowska M; Kuśmierski K; Lichomski J; Machaj EK; Pojda Z; Brudek M; Beresewicz A
    J Physiol Pharmacol; 2007 Dec; 58(4):729-44. PubMed ID: 18195484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.
    Tang YL; Zhao Q; Qin X; Shen L; Cheng L; Ge J; Phillips MI
    Ann Thorac Surg; 2005 Jul; 80(1):229-36; discussion 236-7. PubMed ID: 15975372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
    Zhang J; Chen GH; Wang YW; Zhao J; Duan HF; Liao LM; Zhang XZ; Chen YD; Chen H
    Chin Med J (Engl); 2012 Oct; 125(19):3472-8. PubMed ID: 23044308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
    Bonaros N; Sondermeijer H; Wiedemann D; Schlechta B; Schachner T; Schuster M; Seki T; Martens TP; Itescu S; Kocher AA
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):687-96, 696.e1-2. PubMed ID: 21388641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.
    Bhakta S; Hong P; Koc O
    Cardiovasc Revasc Med; 2006; 7(1):19-24. PubMed ID: 16513519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.